Cited by 313Acute Myeloid Leukemia ResearchGenetic Associations and EpidemiologyCancer Genomics and Diagnostics

Common and rare variant associations with clonal haematopoiesis phenotypes

Open access
Kessler, Michael D., Damask, Amy, O’Keeffe, Sean, Banerjee, Nilanjana, Li, Dadong, Watanabe, Kyoko, Marketta, Anthony, Van Meter, Michael +37 more·2022·Nature

Abstract

Clonal haematopoiesis involves the expansion of certain blood cell lineages and has been associated with ageing and adverse health outcomes 1-5. Here we use exome sequence data on 628,388 individuals to identify 40,208 carriers of clonal haematopoiesis of indeterminate potential (CHIP). Using genome-wide and exome-wide association analyses, we identify 24 loci (21 of which are novel) where germline genetic variation influences predisposition to CHIP, including missense variants in the lymphocytic antigen coding gene LY75, which are associated with reduced incidence of CHIP. We also identify novel rare variant associations with clonal haematopoiesis and telomere length. Analysis of 5,041 health traits from the UK Biobank (UKB) found relationships between CHIP and severe COVID-19 outcomes, cardiovascular disease, haematologic traits, malignancy, smoking, obesity, infection and all-cause mortality. Longitudinal and Mendelian randomization analyses revealed that CHIP is associated with solid cancers, including non-melanoma skin cancer and lung cancer, and that CHIP linked to DNMT3A is associated with the subsequent development of myeloid but not lymphoid leukaemias. Additionally, contrary to previous findings from the initial 50,000 UKB exomes 6, our results in the full sample do not support a role for IL-6 inhibition in reducing the risk of cardiovascular disease among CHIP carriers. Our findings demonstrate that CHIP represents a complex set of heterogeneous phenotypes with shared and unique germline genetic causes and varied clinical implications.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-022-05448-9

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Two recent studies investigating CHIP variants primarily using whole-exome sequencing data from blood cells found no effect or a protective effect on Alzheimer's disease risk.

    “Two recent studies investigating CHIP variants primarily using whole-exome sequencing (WES) data from blood cells found no effect24 or a protective effect25 on AD risk.”

    From Somatic cancer variants enriched in Alzheimer’s disease microglia-like cells drive inflammatory and proliferative states (2026) · cites this paper as [24]

    The paper describes identifying CHIP carriers using exome sequencing data, but the passages from its Phenotypic associations and Longitudinal disease risk sections do not report an Alzheimer’s disease result. Searches for Alzheimer’s disease, AD risk, and dementia found no passage establishing the attributed finding of no effect on Alzheimer’s risk. (LLM, conf=0.72)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 12

  1. Joehanes, R. et al. Integrated genome-wide analysis of expression quantitative trait loci aids interpretation of genomic association studies. Genome Biol. 18, 16 (2017).
  2. Fukaya, T. et al. Conditional ablation of CD205 + conventional dendritic cells impacts the regulation of T-cell immunity and homeostasis in vivo. Proc. Natl Acad. Sci. USA 109, 11288-11293 (2012).
  3. Palamarchuk, A. et al. Tcl1 protein functions as an inhibitor of de novo DNA methylation in B-cell chronic lymphocytic leukemia (CLL). Proc. Natl Acad. Sci. USA 109, 2555-2560 (2012).
  4. Sperling, A. S., Gibson, C. J. & Ebert, B. L. The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia. Nat. Rev. Cancer 17, 5 (2017).
  5. McAdams-DeMarco, M. A., Maynard, J. W., Coresh, J. & Baer, A. N. Anemia and the onset of gout in a population-based cohort of adults: Atherosclerosis Risk in Communities study. Arthritis Res. Ther. 14, R193 (2012).
  6. Bolton, K. L. et al. Clonal hematopoiesis is associated with risk of severe Covid-19. Nat. Commun. 12, 5975 (2021).
  7. Fehrmann, R. S. et al. Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLA. PLoS Genet. 7, e1002197 (2011).
  8. Abbotts, R. et al. DNA methyltransferase inhibitors induce a BRCAness phenotype that sensitizes NSCLC to PARP inhibitor and ionizing radiation. Proc. Natl Acad. Sci. USA 116, 22609-22618 (2019).
  9. Benjamin, D. et al. Calling Somatic SNVs and Indels with Mutect2. Preprint at bioRxiv https://doi.org/10.1101/861054 (2019). · DOI
  10. Pich, O., Reyes-Salazar, I., Gonzalez-Perez, A. & Lopez-Bigas, N. Discovering the drivers of clonal hematopoiesis. Nat. Commun. 13, 4267 (2022).
  11. Costello, M. et al. Discovery and characterization of artifactual mutations in deep coverage targeted capture sequencing data due to oxidative DNA damage during sample preparation. Nucleic Acids Res. 41, e67 (2013).
  12. Watanabe, K., Taskesen, E., Van Bochoven, A. & Posthuma, D. Functional mapping and annotation of genetic associations with FUMA. Nat. Commun. 8, 1826 (2017).

Cited by

Sorted by citations

Authors
Kessler, M. D., Damask, A., O’Keeffe, S., Banerjee, N., Li, D., Watanabe, K., Marketta, A., Van Meter, M., Semrau, S., Horowitz, J., Tang, J., Kosmicki, J. A., Rajagopal, V. M., Zou, Y., Houvras, Y., Ghosh, A., Gillies, C., Mbatchou, J., White, R. R., Verweij, N., Bovijn, J., Parikshak, N. N., LeBlanc, M. G., Jones, M., Regeneron Genetics Center, GHS-RGC DiscovEHR Collaboration, Glass, D. J., Lotta, L. A., Cantor, M. N., Atwal, G. S., Locke, A. E., Ferreira, M. A. R., Deering, R., Paulding, C., Shuldiner, A. R., Thurston, G., Ferrando, A. A., Salerno, W., Reid, J. G., Overton, J. D., Marchini, J., Kang, H. M., Baras, A., Abecasis, G. R., & Jorgenson, E.
Affiliations
Regeneron (United States) (US)
Corresponding author
Jorgenson, Eric
Venue
Nature
Published
2022-11-30
Volume
612
Issue
7939
Pages
301-309
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W4310439055
Cited by
313
References
10
Citations by year
2026: 61 · 2025: 95 · 2024: 97 · 2023: 57 · 2022: 3
FWCI
46.24
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Funders
Medical Research Council (MC_PC_17228)
Topics
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Keywords
clonal hematopoiesis of indeterminate potential, germline genetic variants, rare variant association, genetic susceptibility loci, telomere length, COVID-19 severity, cardiovascular disease, non-melanoma skin cancer, lung cancer, myeloid leukemia, DNMT3A, IL-6 inhibition, cancer susceptibility
MeSH terms
Clonal Hematopoiesis, COVID-19, Cardiovascular Diseases, Humans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review